San Pacific Investments and San Venture holdings are the family holding of Erich Erber dedicated to finance disruptive solutions to improve animal health and sustainable food for tomorrow. Our ultimate goal is to help the world to feed its 10 billion people by 2025. Our mission is to find science based technologies that will bring breakthrough innovations to the industry and help biotech start-ups to develop commercial solution. Untill October 2020 San pacific and San venture Biotech were the holdings of Erber Group AG that has been sold to DSM on October 1st 2020. At the same time Erich Erber decided to carved out some entities and created the new San Group, based in Singapore and focusing on 4 areas: animal health and especially autogenous vaccines with Sanphar , natural solutions for crop protection with Bioferm and Westbridge, investments and collaboration with promising start up focusing on biotechnology and agriculture with San Pacific, and real estate with San Immo. We are now managing the San group of 50MEuro turnover and 200 employees based in Singapore, Austria, Brazil and the US.

METASIA region (Middle East, Turkey Africa, Asia, Australia/NZ) totalizing approximately 1B€ turnover. Lead Business Development projects: M&A, Licensing, Distribution agreementsDevelop strategic rationale, Business cases, define deal structure and terms, negotiate with external partners and develop integration plansAgreements drafting and negotiation

Part of Asia leadership team - Drive Merial external growth across Asian countries through acquisition, licensing, distribution, strategic partnership. In charge of target identification, deal structuring, negotiation, valuation, due diligence, coordination of cross functional, and multinational teams, up to signing closing and integration. Agreement drafting and negotiationsResponsible of alignment with Merial top management and Sanofi Corporate.Member of Merial Asia management committee.

In charge of strategy and business development and licensing for Merial the animal health division of Sanofi Group, in Asia. Agreement drafting and negotiation

Direct worldwide acquisition and strategic alliances for the industry division of bioMérieux group, reporting to the head of the division and member of the executive committee of the division.

In charge of strategic partnerships, licensing and acquisitions

In charge of worldwide Tax and transfer price policy for the group (40 countries). Creation of tax optimization schemes and assessment of tax risks. Follow up of tax and customs audit.

Tax and transfer pricing director in charge of multinational groups. Follow up of tax audits and disputes with the tax authorities. implementation of tax optimization schemes, and transfer prices policy worldwide.